Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes.
- Author:
Jae Seung YUN
1
;
Seung Hyun KO
Author Information
- Publication Type:Review
- Keywords: Type 2 diabetes; Severe hypoglycemia; Hypoglycemia unawareness; Hypoglycemia-associated autonomic failure; Diabetes education
- MeSH: Autonomic Nervous System/physiopathology; Biological Markers/blood; Blood Glucose/*drug effects/metabolism; Diabetes Mellitus, Type 2/blood/complications/diagnosis/*drug therapy/physiopathology; Health Knowledge, Attitudes, Practice; Humans; Hypoglycemia/blood/chemically induced/epidemiology/physiopathology/*prevention & control; Hypoglycemic Agents/*adverse effects; Incidence; Patient Education as Topic; Prevalence; Prognosis; Risk Assessment; Risk Factors
- From:The Korean Journal of Internal Medicine 2015;30(1):6-16
- CountryRepublic of Korea
- Language:English
- Abstract: Hypoglycemia is a major barrier to achieving the glycemic goal in patients with type 2 diabetes. In particular, severe hypoglycemia, which is defined as an event that requires the assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions, is a serious clinical concern in patients with diabetes. If severe hypoglycemia is not managed promptly, it can be life threatening. Hypoglycemia-associated autonomic failure (HAAF) is the main pathogenic mechanism behind severe hypoglycemia. Defective glucose counter-regulation (altered insulin secretion, glucagon secretion, and an attenuated increase in epinephrine during hypoglycemia) and a lack of awareness regarding hypoglycemia (attenuated sympathoadrenal activity) are common components of HAAF in patients with diabetes. There is considerable evidence that hypoglycemia is an independent risk factor for cardiovascular disease. In addition, hypoglycemia has a significant influence on the quality of life of patients with diabetes. To prevent hypoglycemic events, the setting of glycemic goals should be individualized, particularly in elderly individuals or patients with complicated or advanced type 2 diabetes. Patients at high-risk for the future development of severe hypoglycemia should be selected carefully, and intensive education with reinforcement should be implemented.
